| scholarly article | Q13442814 |
| P2093 | author name string | Xiaodong Cheng | |
| Junmin Peng | |||
| Da Jia | |||
| Robert E Collins | |||
| Doris R Powell | |||
| Paula M Vertino | |||
| Dipali Sharma | |||
| Krithika Subramanian | |||
| Priya Kapoor-Vazirani | |||
| P2860 | cites work | Regulation of chromatin structure by site-specific histone H3 methyltransferases | Q24290115 |
| p53 is regulated by the lysine demethylase LSD1 | Q24292925 | ||
| Structural basis for the methylation site specificity of SET7/9 | Q24301341 | ||
| Regulation of p53 activity through lysine methylation | Q24311514 | ||
| LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription | Q24312958 | ||
| Repression of p53 activity by Smyd2-mediated methylation | Q24315991 | ||
| Identification of the MLL2 complex as a coactivator for estrogen receptor alpha | Q24316007 | ||
| Gene-specific modulation of TAF10 function by SET9-mediated methylation | Q24337399 | ||
| Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination | Q24556492 | ||
| In vitro and in vivo analyses of a Phe/Tyr switch controlling product specificity of histone lysine methyltransferases | Q24645737 | ||
| Structural basis for the product specificity of histone lysine methyltransferases | Q24646957 | ||
| Set9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation | Q24672514 | ||
| The estrogen receptor-alpha A908G (K303R) mutation occurs at a low frequency in invasive breast tumors: results from a population-based study | Q25257794 | ||
| TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers | Q28139273 | ||
| NSD1 is essential for early post-implantation development and has a catalytically active SET domain | Q28593118 | ||
| Dynamic Regulation of Histone Lysine Methylation by Demethylases | Q29036779 | ||
| Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark | Q29614516 | ||
| Genome-wide analysis of estrogen receptor binding sites | Q29614765 | ||
| Cellular and molecular pharmacology of antiestrogen action and resistance | Q31921111 | ||
| Oestrogen receptors - an overview | Q33711233 | ||
| The SRC family of nuclear receptor coactivators | Q33860695 | ||
| Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities | Q33922863 | ||
| Direct acetylation of the estrogen receptor alpha hinge region by p300 regulates transactivation and hormone sensitivity | Q33940612 | ||
| Purification and functional characterization of a histone H3-lysine 4-specific methyltransferase. | Q34108153 | ||
| Nuclear receptor coregulators: multiple modes of modification | Q34537625 | ||
| Ligand-dependent transcription of estrogen receptor alpha is mediated by the ubiquitin ligase EFP. | Q34617201 | ||
| Acetylation of estrogen receptor alpha by p300 at lysines 266 and 268 enhances the deoxyribonucleic acid binding and transactivation activities of the receptor | Q34698474 | ||
| Nuclear receptor modifications and endocrine cell proliferation | Q35207718 | ||
| Histone H3 lysine 9 methyltransferase G9a is a transcriptional coactivator for nuclear receptors | Q35589266 | ||
| Estrogen receptor alpha is a putative substrate for the BRCA1 ubiquitin ligase | Q35749504 | ||
| Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer | Q35794355 | ||
| Risk factors for breast cancer characterized by the estrogen receptor alpha A908G (K303R) mutation | Q35906333 | ||
| Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status. | Q35976106 | ||
| Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors | Q36014589 | ||
| Effects of endocrine therapy on steroid-receptor content of breast cancer | Q36046259 | ||
| Coregulators in nuclear estrogen receptor action: from concept to therapeutic targeting | Q36361043 | ||
| A histone methyltransferase is required for maximal response to female sex hormones | Q36701489 | ||
| Proteasome-dependent degradation of the human estrogen receptor | Q37160826 | ||
| Lysine trimethylation of retinoic acid receptor-alpha: a novel means to regulate receptor function | Q38305996 | ||
| An assessment of the role of domain F and PEST sequences in estrogen receptor half-life and bioactivity | Q38313711 | ||
| Tamoxifen resistance by a conformational arrest of the estrogen receptor alpha after PKA activation in breast cancer | Q38340180 | ||
| Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling | Q38356127 | ||
| Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents | Q40124566 | ||
| P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation | Q40321973 | ||
| E6AP and calmodulin reciprocally regulate estrogen receptor stability. | Q40346484 | ||
| Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity. | Q40479849 | ||
| Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor | Q40493369 | ||
| Neurite-localized estrogen receptor-alpha mediates rapid signaling by estrogen | Q40634138 | ||
| Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation | Q40930380 | ||
| Calmodulin is a selective modulator of estrogen receptors | Q43974253 | ||
| Ubiquitination of the Rat Uterine Estrogen Receptor: Dependence on Estradiol | Q71970742 | ||
| A hypersensitive estrogen receptor-alpha mutation in premalignant breast lesions | Q74181062 | ||
| The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators | Q74265958 | ||
| It takes a PHD to interpret histone methylation | Q79853386 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cell biology | Q7141 |
| estrogen | Q277954 | ||
| P304 | page(s) | 336-47 | |
| P577 | publication date | 2008-05-09 | |
| P1433 | published in | Molecular Cell | Q3319468 |
| P1476 | title | Regulation of Estrogen Receptor α by the SET7 Lysine Methyltransferase | |
| P478 | volume | 30 |
| Q34144669 | (R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells |
| Q83047013 | A 629RKLKK633 motif in the hinge region controls the androgen receptor at multiple levels |
| Q42022480 | A chemical method for labeling lysine methyltransferase substrates. |
| Q34324556 | A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes |
| Q38980243 | A functional interplay between ZNF217 and estrogen receptor alpha exists in luminal breast cancers |
| Q27666366 | A methylation and phosphorylation switch between an adjacent lysine and serine determines human DNMT1 stability |
| Q38971202 | Adsorption of guanidinium collectors on aluminosilicate minerals - a density functional study |
| Q61829990 | Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer |
| Q40510451 | Bioorthogonal profiling of protein methylation (BPPM) using an azido analog of S-adenosyl-L-methionine |
| Q38013734 | Chromatin modifications associated with diabetes |
| Q38090433 | Context-specific regulation of cancer epigenomes by histone and transcription factor methylation |
| Q45139842 | Coordinate regulation of estrogen receptor β degradation by Mdm2 and CREB-binding protein in response to growth signals |
| Q38329400 | Critical roles of non-histone protein lysine methylation in human tumorigenesis |
| Q37851398 | Crosstalk of TGF-β and estrogen receptor signaling in breast cancer |
| Q38476540 | Deep sequencing reveals novel Set7 networks. |
| Q36515312 | Deposition of 5-Methylcytosine on Enhancer RNAs Enables the Coactivator Function of PGC-1α. |
| Q36589361 | Derailed estrogen signaling and breast cancer: an authentic couple. |
| Q89038157 | Development of Novel Inhibitors for Histone Methyltransferase SET7/9 based on Cyproheptadine |
| Q34998116 | Direct evidence for methyl group coordination by carbon-oxygen hydrogen bonds in the lysine methyltransferase SET7/9 |
| Q28115198 | Direct methylation of FXR by Set7/9, a lysine methyltransferase, regulates the expression of FXR target genes |
| Q34620820 | Dynamics of histone lysine methylation: structures of methyl writers and erasers |
| Q64067892 | EZH2 Regulates Protein Stability via Recruiting USP7 to Mediate Neuronal Gene Expression in Cancer Cells |
| Q38557842 | Emerging roles of lysine methylation on non-histone proteins |
| Q35998418 | Engineering of Methylation State Specific 3xMBT Domain Using ELISA Screening |
| Q36337694 | Epigenetic Therapy in Breast Cancer |
| Q38244664 | Epigenetic regulation of female puberty. |
| Q37452855 | Epigenetic regulation: methylation of histone and non-histone proteins |
| Q36856318 | Epigenetic targeting in breast cancer: therapeutic impact and future direction |
| Q37390178 | Epigenetics meets estrogen receptor: regulation of estrogen receptor by direct lysine methylation |
| Q34010413 | Estrogen receptor (ER) α mutations in breast cancer: hidden in plain sight |
| Q34112728 | Estrogen receptor mutations and changes in downstream gene expression and signaling |
| Q34040118 | Fluorescence-based methods for screening writers and readers of histone methyl marks |
| Q43245229 | Formulating a fluorogenic assay to evaluate S-adenosyl-L-methionine analogues as protein methyltransferase cofactors |
| Q39738771 | Functional interplay between acetylation and methylation of the RelA subunit of NF-kappaB. |
| Q35235860 | Functional regulation of hypoxia inducible factor-1α by SET9 lysine methyltransferase. |
| Q36690093 | G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression. |
| Q49565076 | Histone Methyltransferase Setd7 Regulates Nrf2 Signaling Pathway by Phenethyl Isothiocyanate and Ursolic Acid in Human Prostate Cancer Cells |
| Q38591399 | Histone Modifications and Asthma. The Interface of the Epigenetic and Genetic Landscapes |
| Q38796064 | Histone Modifications and Cancer |
| Q36421138 | Histone demethylases and cancer |
| Q36812958 | Histone methyl transferases and demethylases; can they link metabolism and transcription? |
| Q45966440 | Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond. |
| Q52677294 | Identification and Characterizations of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Scaffold Hopping- and 2D-Molecular Fingerprint-Based Similarity Search. |
| Q89356206 | Identification of Rpl29 as a major substrate of the lysine methyltransferase Set7/9 |
| Q50209897 | Inhibition of Methyltransferase Setd7 Allows the In Vitro Expansion of Myogenic Stem Cells with Improved Therapeutic Potential. |
| Q38740496 | Inhibitors of Protein Methyltransferases and Demethylases. |
| Q89783056 | Interaction of the Anti-Proliferative GPER Inverse Agonist ERα17p with the Breast Cancer Cell Plasma Membrane: From Biophysics to Biology |
| Q38839983 | KMT Set7/9 affects genotoxic stress response via the Mdm2 axis |
| Q38965954 | KMTase Set7/9 is a critical regulator of E2F1 activity upon genotoxic stress |
| Q35223761 | Kinase consensus sequences: a breeding ground for crosstalk |
| Q37632309 | Ligand binding promotes CDK-dependent phosphorylation of ER-alpha on hinge serine 294 but inhibits ligand-independent phosphorylation of serine 305. |
| Q35062217 | Liganded and unliganded activation of estrogen receptor and hormone replacement therapies |
| Q90191151 | Lysine Methylation Regulators Moonlighting outside the Epigenome |
| Q38830359 | Lysine Methyltransferase SETD7 (SET7/9) Regulates ROS Signaling through mitochondria and NFE2L2/ARE pathway |
| Q34609949 | Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase |
| Q38266428 | Lysine methylation in cancer: SMYD3-MAP3K2 teaches us new lessons in the Ras-ERK pathway. |
| Q42371486 | Lysine methylation of FEN1 by SET7 is essential for its cellular response to replicative stress |
| Q24306845 | Lysine methylation of FOXO3 regulates oxidative stress-induced neuronal cell death |
| Q37608465 | Lysine methylation of progesterone receptor at activation function 1 regulates both ligand-independent activity and ligand sensitivity of the receptor |
| Q38706561 | Lysine methylation of promoter-bound transcription factors and relevance to cancer |
| Q64101463 | Lysine methylation of transcription factors in cancer |
| Q39742282 | Lysine methylation regulates the pRb tumour suppressor protein |
| Q37970950 | Lysine methylation: beyond histones |
| Q41961371 | Lysyl 5-hydroxylation, a novel histone modification, by Jumonji domain containing 6 (JMJD6) |
| Q52876304 | MED12 protein expression in breast fibroepithelial lesions: correlation with mutation status and oestrogen receptor expression. |
| Q36209138 | Methylation by Set9 modulates FoxO3 stability and transcriptional activity. |
| Q90256138 | Methylation of Aurora kinase A by MMSET reduces p53 stability and regulates cell proliferation and apoptosis |
| Q24300912 | Methylation of the retinoblastoma tumor suppressor by SMYD2 |
| Q39592554 | Methylation-mediated regulation of E2F1 in DNA damage-induced cell death |
| Q30437467 | Methyltransferase Set7/9 maintains transcription and euchromatin structure at islet-enriched genes |
| Q38826180 | Methyltransferase-like 17 physically and functionally interacts with estrogen receptors |
| Q37332446 | Minireview: role of protein methylation and demethylation in nuclear hormone signaling. |
| Q30570945 | Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives |
| Q37755682 | Modulation of steroid hormone receptor activity |
| Q24317508 | Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit |
| Q33500874 | New stably transfected bioluminescent cells expressing FLAG epitope-tagged estrogen receptors to study their chromatin recruitment |
| Q26849574 | Nuclear receptors and epigenetic regulation: opportunities for nutritional targeting and disease prevention |
| Q38102573 | On your histone mark, SET, methylate! |
| Q41439912 | Opposite Effects of SET7/9 on Apoptosis of Human Acute Myeloid Leukemia Cells and Lung Cancer Cells |
| Q33915087 | Palmitoylation: a protein S-acylation with implications for breast cancer |
| Q34070890 | Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity |
| Q33783165 | Protein arginine methyltransferase 6 regulates multiple aspects of gene expression |
| Q37590090 | Protein methyltransferases as a target class for drug discovery |
| Q35747225 | Purification of CFTR for mass spectrometry analysis: identification of palmitoylation and other post-translational modifications |
| Q64902344 | RUNX family: Oncogenes or tumor suppressors (Review). |
| Q36782319 | Reduced expression of SET7/9, a histone mono-methyltransferase, is associated with gastric cancer progression |
| Q37404711 | Regulation of NF-kappaB activity through lysine monomethylation of p65. |
| Q37655166 | Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy |
| Q37256023 | Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation |
| Q35149921 | Regulation of p53 function by lysine methylation |
| Q39642231 | Regulation of the androgen receptor by SET9-mediated methylation |
| Q39362468 | Regulation of tumor suppressor p53 and HCT116 cell physiology by histone demethylase JMJD2D/KDM4D. |
| Q35610555 | Repression of hypoxia-inducible factor α signaling by Set7-mediated methylation |
| Q37615671 | SET for life: biochemical activities and biological functions of SET domain-containing proteins |
| Q27663757 | SET7/9 Catalytic Mutants Reveal the Role of Active Site Water Molecules in Lysine Multiple Methylation |
| Q35860498 | SET7/9 Enzyme Regulates Cytokine-induced Expression of Inducible Nitric-oxide Synthase through Methylation of Lysine 4 at Histone 3 in the Islet β Cell |
| Q37580675 | SET7/9 mediated methylation of non-histone proteins in mammalian cells |
| Q34645055 | SET7/9 methylation of the pluripotency factor LIN28A is a nucleolar localization mechanism that blocks let-7 biogenesis in human ESCs |
| Q89900066 | SET7/9 promotes multiple malignant processes in breast cancer development via RUNX2 activation and is negatively regulated by TRIM21 |
| Q35006936 | SET7/9-dependent methylation of ARTD1 at K508 stimulates poly-ADP-ribose formation after oxidative stress |
| Q24339520 | SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities |
| Q37037723 | SET9-Mediated Regulation of TGF-β Signaling Links Protein Methylation to Pulmonary Fibrosis |
| Q51418450 | SETD7 Drives Cardiac Lineage Commitment through Stage-Specific Transcriptional Activation. |
| Q35927143 | SETD7 Regulates the Differentiation of Human Embryonic Stem Cells |
| Q34752545 | Selective mutations in estrogen receptor alpha D-domain alters nuclear translocation and non-estrogen response element gene regulatory mechanisms |
| Q28833172 | Set7 mediated Gli3 methylation plays a positive role in the activation of Sonic Hedgehog pathway in mammals |
| Q27667296 | Structural Insights for MPP8 Chromodomain Interaction with Histone H3 Lysine 9: Potential Effect of Phosphorylation on Methyl-Lysine Binding |
| Q27653816 | Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294 |
| Q27653167 | Structural origins for the product specificity of SET domain protein methyltransferases |
| Q37829702 | Structure and function of histone H3 lysine 9 methyltransferases and demethylases |
| Q88993597 | Structure-Activity Relationship Studies on (R)-PFI-2 Analogues as Inhibitors of Histone Lysine Methyltransferase SETD7 |
| Q27684252 | Structures of histone methyltransferase SET7/9 in complexes with adenosylmethionine derivatives |
| Q34208487 | Substrate and product specificities of SET domain methyltransferases |
| Q33382611 | Systematic mapping of posttranslational modifications in human estrogen receptor-alpha with emphasis on novel phosphorylation sites |
| Q35629831 | Targeting protein lysine methylation and demethylation in cancers. |
| Q39777846 | The Cellular lysine methyltransferase Set7/9-KMT7 binds HIV-1 TAR RNA, monomethylates the viral transactivator Tat, and enhances HIV transcription. |
| Q37315335 | The Epigenetics of Normal Pregnancy |
| Q40731101 | The HIV-1 Tat Protein Is Monomethylated at Lysine 71 by the Lysine Methyltransferase KMT7 |
| Q35949401 | The HPV E6 oncoprotein targets histone methyltransferases for modulating specific gene transcription. |
| Q92815340 | The Peptide ERα17p Is a GPER Inverse Agonist that Exerts Antiproliferative Effects in Breast Cancer Cells |
| Q27655448 | The ankyrin repeat domain of Huntingtin interacting protein 14 contains a surface aromatic cage, a potential site for methyl-lysine binding |
| Q26853164 | The functional diversity of protein lysine methylation |
| Q38972579 | The genetic regulation of transcription in human endometrial tissue |
| Q47313741 | The methyltransferase SET9 regulates TGFB1 activation of renal fibroblasts via interaction with SMAD3. |
| Q39157599 | The mystery of puberty initiation: genetics and epigenetics of idiopathic central precocious puberty (ICPP). |
| Q36962818 | The transcription factor GATA1 and the histone methyltransferase SET7 interact to promote VEGF-mediated angiogenesis and tumor growth and predict clinical outcome of breast cancer |
| Q34354154 | The transcriptional control of female puberty |
| Q35352055 | Transcriptional activity of the islet β cell factor Pdx1 is augmented by lysine methylation catalyzed by the methyltransferase Set7/9. |
| Q27009508 | Transcriptional regulation by the Set7 lysine methyltransferase |
| Q40774279 | Tumor suppressor SET9 guides the epigenetic plasticity of breast cancer cells and serves as an early-stage biomarker for predicting metastasis. |
| Q35914643 | Tumor suppressor function of RUNX3 in breast cancer |
| Q35688891 | Ubiquitylation of nuclear receptors: new linkages and therapeutic implications. |
| Q41028199 | aKMT Catalyzes Extensive Protein Lysine Methylation in the Hyperthermophilic Archaeon Sulfolobus islandicus but is Dispensable for the Growth of the Organism |
| Q24296905 | ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs |
Search more.